Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUPENTIXOL DECANOATE vs FLURAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLUPENTIXOL DECANOATE vs FLURAZEPAM: Safety Overview

Metric FLUPENTIXOL DECANOATE FLURAZEPAM
Total FAERS Reports 389 976
Deaths Reported 40 94
Death Rate 10.3% 9.6%
Hospitalizations 94 509
Average Patient Age 35.9 yrs 49.5 yrs
% Female Patients 60.6% 66.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Chartwell RX, LLC
Route N/A ORAL
Marketing Status N/A Discontinued